Genetron Holdings Financials

Genetron Holdings Stock Summary

Genetron Holdings competes with Psychemedics, Sera Prognostics, DarioHealth Corp, Biodesix, and Aclaris Therapeutics. Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the Peoples Republic of China. Genetron Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1154 people.

Genetron Holdings Key Financial Ratios

Genetron Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genetron Holdings's current stock value. Our valuation model uses many indicators to compare Genetron Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genetron Holdings competition to find correlations between indicators driving Genetron Holdings's intrinsic value. More Info.Genetron Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genetron Holdings' earnings, one of the primary drivers of an investment's value.

Genetron Holdings Market Pulse

Along with financial statement analysis, the daily predictive indicators of Genetron Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genetron Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genetron Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Genetron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genetron Holdings's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.